http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012161803-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea127f3bfab777c4de13f65c5548e85f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387d427fd93ee185ea4b8b01bc2666b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89dc17b8fe6382575d17a594b7b93a49 |
| publicationDate | 2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2012161803-A1 |
| titleOfInvention | Analyzing the fmr1 gene |
| abstract | Methods of screening a human for risk of autoimmunity, pregnancy chances, malignancies, clinical effectiveness of an androgen, and increased embryo quality are disclosed. The methods may include isolating the human's FMR1 gene, wherein the FMR1 gene has a first allele and a second allele, measuring the number of triple CGG repeats on each of the first and second alleles, wherein the measuring step is conducted through use of an assay, and identifying the human as at risk for autoimmunity, decreased or increased pregnancy chances, malignancies, decreased or increased clinical effectiveness of an androgen, or increased embryo quality, by comparing the triple CGG repeat numbers for each of the first and second alleles to a range of 26-34 triple CGG repeats. |
| priorityDate | 2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.